/ Print /

Pharmacy Best Practices

New strategies for managing drug spend: RA, Cancer, Hep C
New strategies for managing drug spend: RA, Cancer, Hep CThe proliferation of specialty drugs has prompted new techniques for keeping costs in tow.
Cannabinoid-based drug pipeline grows: 4 ways to prepareNew treatment indications are under investigation for the use of cannabinoid-based drugs. Are you ready?
Payers to pharma: Here’s what we’re missing in hep C drugsA Precision for Value survey highlights what can be done in order to encourage payers to ease coverage policies for these drugs in the next wave of HCV treatment.
Express Scripts’ 2016 Drug Trend Report: 7 things to knowReport highlights spending trends in key areas, including specialty medications, oncology, diabetes, and inflammatory conditions.
Ten ways the FDA is addressing the opioid epidemicScott Winiecki, MD, of the FDA Center for Drug Evaluation and Research, shares how the FDA is working to address the opioid epidemic.
Top strategies for incorporating PDMP data into physician work flowHow can physicians, already struggling to keep up with mounting regulations and larger patient loads, use PDMPs in more effective and efficient ways?
New diabetes medications help address linked diseasesExperts share updates on new diabetes medications, and provide an overview of what’s coming.
Poll: Few consumers trust health orgs, pharmaA new report has troubling findings for payers, providers, and technology companies. Here are the key takeaways, and reactions from experts.
Top 3 pharmacy challenges in 2017: Two-pronged solutionHere are three pharmacy challenges facing healthcare executives and a two-pronged solution to help solve them.
Top challenges in cancer careCancer drug costs remain the most critical challenge in care, among other things.